GSK2210875 is a novel orally bioavailable mGluR5 antagonist. References: Pilla M, Andreoli M, Tessari M, Delle-Fratte S, Roth A, Butler S, Brown F, Shah P, Bettini E, Cavallini P, Benedetti R, Minick D, Smith P, Tehan B, D'Alessandro P, Lorthioir O, Ball C, Garzya V, Goodacre C, Watson S. The identification of novel orally active mGluR5 antagonist GSK2210875. Bioorg Med Chem Lett. 2010 Dec 15;20(24):7521-4. doi: 10.1016/j.bmcl.2010.09.120. PubMed PMID: 21051228.

纯度：≥98%

CAS：1170668-67-3